Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 7.58B | 5.71B | 4.58B | 4.17B | 3.67B |
Gross Profit | 3.20B | 2.69B | 2.24B | 2.08B | 1.62B |
EBITDA | 200.26M | 319.35M | 200.51M | 332.47M | 177.24M |
Net Income | -244.55M | 58.30M | 31.59M | 147.85M | 59.32M |
Balance Sheet | |||||
Total Assets | 8.70B | 6.19B | 4.53B | 3.39B | 3.19B |
Cash, Cash Equivalents and Short-Term Investments | 815.00M | 1.13B | 975.26M | 1.21B | 1.22B |
Total Debt | 6.14B | 3.48B | 2.09B | 995.35M | 1.15B |
Total Liabilities | 7.15B | 4.42B | 2.80B | 1.67B | 1.63B |
Stockholders Equity | 1.55B | 1.77B | 1.73B | 1.72B | 1.56B |
Cash Flow | |||||
Free Cash Flow | -456.86M | 41.91M | -317.08M | 166.38M | -118.78M |
Operating Cash Flow | -319.20M | 172.02M | -233.15M | 309.27M | -99.96M |
Investing Cash Flow | -354.88M | -193.60M | -516.91M | -149.47M | -296.84M |
Financing Cash Flow | 358.26M | 177.13M | 511.11M | -160.97M | 464.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥2.09B | 9.81 | ― | 1.72% | -54.67% | ||
70 Outperform | ¥1.73B | 15.65 | 2.75% | 5.70% | 390.26% | ||
56 Neutral | HK$24.71B | 3.78 | -3.23% | 5.89% | 0.25% | -59.97% | |
54 Neutral | ¥2.26B | ― | 1.60% | 32.79% | -518.42% | ||
51 Neutral | ¥1.90B | 2,022.82 | 1.97% | 8.89% | -129.54% | ||
40 Underperform | ¥1.45B | ― | ― | -7.04% | 83.17% |